Sirolimus Oral Product: Clinical Trials

3 trials of Sirolimus Oral Product, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 4, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 42Completed 1, Unknown 1
Phase 11Completed 1
Phase 21Completed 1

Follow Sirolimus Oral Product: new trials by email Literature Review of Sirolimus Oral Product trials Research Report on Sirolimus Oral Product

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)
Sirolimus Oral Product, propranolol - Hemangioendothelioma of Liver
Phase 4UnknownShanghai Children's Medical Center362020-07-012020-05-29
Safety of Simvastatin in LAM and TSC
Simvastatin, Sirolimus Oral Product, Everolimus Oral Product - Lymphangioleiomyomatosis, Tuberous Sclerosis Complex
Phase 1 / Phase 2CompletedUniversity of Pennsylvania102014-03-012020-08-25
Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation
Sirolimus Oral Product, Mycophenolate Mofetil - Diabetes Mellitus, Type 1
Phase 4CompletedInstitute for Clinical and Experimental Medicine2382004-01-012021-04-26

Conditions studied

Diabetes Mellitus, Type 1 (1)  ·  Lymphangioleiomyomatosis (1)  ·  Tuberous Sclerosis (1)

Sponsors

Institute for Clinical and Experimental Medicine (1)  ·  Shanghai Children's Medical Center (1)  ·  University of Pennsylvania (1)

Countries

China (1)  ·  Czechia (1)  ·  United States (1)

Top investigators

Frank McCormack, MD (1)  ·  Frantisek Saudek, MD (1)  ·  Maryl Kreider, MD, MSCE (1)  ·  Song Gu, Doctor (1)  ·  Vera P Krymskaya, PhD, MBA (1)

Results publications

PMID 21482669, PMID 31561278